US$ 20.39
glp 1 not working Does stopping and restarting a GLP-1 medicine make it less effective? There is no data to support this. I've seen it anecdotally both ways. Sometimes more effective. Sometimes less. There is no The science of GLP1 medicine
Description
Funding This work was supported by Statutory Funds of the Laboratory of Immunoendocrinology, Maj Institute of Pharmacology, Cracow, Poland
Moberly SP, Mather KJ, Berwick ZC, Owen MK, Goodwill AG, Casalini ED, Hutchins GD, Green MA, Ng Y, Considine RV, Perry KM, Chisholm RL, Tune JD: Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus

The physiological basis of functional hyperaemia (see Glossary) is thought to reflect a vasoactive effect on the brain capillaries by the local accumulation of metabolic by-products during synaptic activity (e.g., lactate, CO 2 , H + ) and/or the active generation of vasodilatory mediators (e.g., NOnitric oxide, adenosine, ATP, K + ) [106,110,111]

These advances again produce better long-term glycemic control and stable metabolic results, reinforcing their clinical value
in August 2023, Merck acquired a smaller biotech firm specializing in GLP-1 compounds, aiming to bolster its pipeline

N Engl J Med 387 , 205216 (2022)
